Cubist Systematic Strategies, LLC Lian Bio Transaction History

Cubist Systematic Strategies, LLC

  • $17.3 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024
BUY
$1.33 - $4.6 $25,508 - $88,223
19,179 New
19,179 $85,000
Q2 2022

Aug 15, 2022
BUY
$2.15 - $6.01 $69,445 - $194,123
32,300 New
32,300 $70,000
Q1 2022

May 16, 2022
SELL
$2.8 - $6.21 $31,065 - $68,899
-11,095 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$6.14 - $16.2 $68,123 - $179,739
11,095 New
11,095 $68,000

Others Institutions Holding LIAN

# of Institutions
4
Shares Held
1.09M
Call Options Held
0
Put Options Held
0
View Full List

About LianBio

LIAN Quotes by TradingView
  • Ticker LIAN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 108,354,000
  • Market Cap $32.5M
  • Description
  • LianBio, a biopharmaceutical company, engages in developing and commercializing medicines for cardiovascular, oncology, respiratory, opthalmology, and inflammatory diseases in China and other Asian countries. The company develops mavacamten for the treatment of obstructive and non-obstructive hypertrophic cardiomyopathy, and heart failure with p...
More about LIAN
Track This Portfolio

Track Cubist Systematic Strategies, LLC Portfolio

Follow Cubist Systematic Strategies, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email